Back
Microsoft Vs. Kymera Therapeutics Sector Stock Comparison
Buy
67
MSFT
Microsoft
Last Price:
$487.72
Seasonality Move:
1.98%
Buy
78
KYMR
Kymera Therapeutics
Last Price:
$46.82
Seasonality Move:
30.84%
Buy
78
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $46.29. The Score for KYMR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
MSFT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.68 | Buy |
Relative Strength Index (14 RSI): | 74.1 | Buy |
Chaikin Money Flow: | 19153727 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (456.66 - 476.44) | Buy |
Bollinger Bands (100): | (380.46 - 451.9) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.85 | Buy |
Relative Strength Index (14 RSI): | 68.48 | Buy |
Chaikin Money Flow: | 162752 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.57 - 48.03) | Buy |
Bollinger Bands (100): | (27.29 - 40.83) | Buy |
MSFT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 478.41 | Buy |
20-day SMA: | 469.25 | Buy |
50-day SMA: | 437.03 | Buy |
200-day SMA: | 421.25 | Buy |
8-day EMA: | 478.22 | Buy |
20-day EMA: | 468.84 | Buy |
50-day EMA: | 446.51 | Buy |
200-day EMA: | 422.03 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.8 | Sell |
20-day SMA: | 42.14 | Buy |
50-day SMA: | 34.87 | Buy |
200-day SMA: | 39.61 | Buy |
8-day EMA: | 46.14 | Buy |
20-day EMA: | 42.9 | Buy |
50-day EMA: | 37.83 | Buy |
200-day EMA: | 37 | Buy |
Microsoft Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $1.71 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.40 per share.
Microsoft Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |